CINECA IRIS Institutional Research Information System

Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 91 a 110 di 501
Titolo Data di pubblicazione Autore(i) File
COEXISTENCE OF A JAK2 MUTATED CLONE MAY CAUSE HEMATOLOGIC RESISTANCE (HRES) TO TIROSYN-KINASE INHIBITORS (TKI) IN CHRONIC MYELOID LEUKEMIA (CML) 2009 Fava C; Rege-Cambrin G; Ferrero D; Ulisciani S; Serra A; Giugliano E; Fava M; Gottardi E; Giaretto L; Saglio G
Colony stimulating activity (CSA) in human adult and cord blood. Interaction between leucocytes and plasma. 1980 FOA' R ;AGLIETTA M ;SACCHETTI L ;INCARBONE E ;GABUTTI V
Combination of haplotypes of the HL-A system as a possible mechanism for gametic or zygotic selection 1969 PIAZZA A ;MATTIUZ PL ;CEPPELLINI R
Comorbidities influence compliance and developement of pleural effusions in elderly chronic myeloid leukemia (CML) patients treated with dasatinib. 2009 Breccia M.; Latagliata R.; Stagno F.; Luciano L.; Gozzini A.; Annunziata M.; De Matteis S.; Albano F.; Rege-Cambrin G.; Pregno P.; Pacilli M.; Abruzzese E.; Martino B.; Tiribelli M.; Russo Rossi A.; Specchia G.; Sica S.; Vitolo U.; Montefusco E.; Fava C.; Ferrara F.; Santini V.; Pane F.; Di Raimondo F.; Alimena G.
Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. 2003 A. PIGA; C. GAGLIOTI; E. FOGLIACCO; F. TRICTA
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 2020 Lorentino, Francesca; Sacchi, Nicoletta; Oldani, Elena; Miotti, Valeria; Picardi, Alessandra; Gallina, Anna Maria; Crivello, Pietro; Bernasconi, Paolo; Saccardi, Riccardo; Farina, Lucia; Benedetti, Fabio; Cerno, Michela; Grassi, Anna; Bruno, Benedetto; Patriarca, Francesca; Ciceri, Fabio; Fleischhauer, Katharina; Vago, Luca; Bonifazi, Francesca
Comparison between ABVD + radiotherapy and MOPP + radiotherapy in Hodgkin's disease stage II and III [CONFRONTO FRA ABVD + RADIOTERAPIA E MOPP + RADIOTERAPIA NEL MORBO DI HODGKIN IN STADIO II E III] 1994 Ficara; F.; Levis; A.; Bertini; M.; Ricardi; U.; Vitolo; U.; Resegotti; L.
COMPARISON OF DIFFERENT RQ-PCR DESIGN STRATEGIES FOR MINIMAL RESIDUAL DISEASE DETECTION IN LYMPHOPROLIFERATIVE DISORDERS: CORRELATION BETWEEN IMMUNOGLOBULIN GENE MUTATION LOAD AND RQ-PCR PERFORMANCE 2013 Della Starza I.; Cavalli M.; Del Giudice I.; Monitillo L
COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4 2015 Fava, C; Gottardi, E; Berchialla, P; Rege-Cambrin, G; Varotto, M; Daraio, F; Crasto, F; Lorenzatti, R; Volpengo, A; Fantino, C; Dani, N; Barberio, D; Dogliotti, I; Saglio, G
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: a multicentric italian survey 2012 D'Arena G; Laurenti L; Del Poeta G; Grossi A; Coscia M; Mometto G; Chiarenza A; Selleri C; Vigliotti ML; Pozzato G; Nunziata G; La Sala A; Villa MR; Simeon V; Deaglio S; De Feo V; Musto P
Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment. 1990 Tarella C; Ferrero D; Siena S; Gallo E; Bondesan P; Bregni M; Pileri A; Gianni AM.
Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment. 1990 TARELLA C ;FERRERO D ;SIENA S ;GALLO E ;BONDESAN P ;BREGNI M ;PILERI A ;GIANNI AM
Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy. 1990 PALUMBO AP ;GARINO AL ;FRIERI R ;GALLONE G ;BOCCADORO M ;PILERI A
Conventional and novel tools for defining the risk of the individual patient with chronic myeloid leukemia and for monitoring treatment 2004 G. SAGLIO; D. CILLONI
Correlation between fatigue and hemoglobin level in multiple myeloma patients: results of a cross-sectional study 2005 PALUMBO A; PETRUCCI MT; LAUTA VM; MUSTO P; CARAVITA T; BARBUI AM; NUNZI M; M. BOCCADORO; ITALIAN MULTIPLE MYELOMA STUDY GROUP
Corticosteroids can reverse severe imatinib-induced hepatotoxicity 2006 FERRERO D; POGLIANI EM; REGE-CAMBRIN G; FAVA C; MATTIOLI G; DELLACASA C; CAMPA E; PERFETTI P; FUMAGALLI M; BOCCADORO M
A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS 2015 Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, E; Stagno, F; Bonifacio, M; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G
Cumulative analysis of post induction WT1 values and WT1 onset/post induction ratio as an udeful tool for a risk stratification of acute myeloid leukemia patients 2015 Coluzzi, S.; Introcaso, T.; Iallorenzi, P.; Di Nardo, E.; Pascale, Sp.; Nuccorini, R.; Attolico, I.; Matturro, A.; Amendola, A.; Cimminiello, M.; Vertone, D.; Filardi, N.; Pizzuti, M.
Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms 2014 T. I. Mughal;A. M. Vannucchi;S. Soverini;A. Bazeos;R. Tibes;G. Saglio;O. Abdel-Wahab;A. Pardanani;R. Hehlmann;T. Barbui;R. Van Etten;A. Tefferi;J. M. Goldman
Current role and future developments of radiotherapy in Hodgkin's lymphoma. 2011 Ricardi U; Filippi AR
Mostrati risultati da 91 a 110 di 501
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile